Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |